Understanding GLP Drugs: What They Are and Why People Take Them We have probably all seen the recent press on GLP drugs, or glucagon-like peptide-1 receptor agonists
Because, as she put it, I have a piece of toast and a glass of water in the morning, and I'm not hungry anymore. And of course, you can't live on a piece of toast and a glass of water
Lilly says it submitted the drug for overweight or obesity review in 2025 and plans a type 2 diabetes submission in 2026
As a consequence, levels of adherence are lower than for people with diabetes, as demonstrated by another study that applied the same metric of adherence to people using GLP-1s to treat obesity: 40.1% for Ozempic (semaglutide, Novo Nordisk), 31.5% for weekly injectable Wegovy and just 15% for daily injectable Saxenda (liraglutide, Novo Nordisk).10 This suggests that greater expectation management is required to maintain users faith in the value and purpose of what they are doing
the other half is fiercely protecting the energy you have
